Lakeway, TX -- (SBWIRE) -- 03/01/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Northstar Realty Finance Corp. (NYSE:NRF) shares jumped 3.59% and closed at $8.95 in the last trading session. The company, on Feb. 20, announced that it has priced an underwritten public offering of 30,000,000 shares of common stock at a public offering price of $8.39 per share. The Company has granted the underwriters a 30-day option to purchase up to 4,500,000 additional shares of common stock. The offering is expected to close on February 25, 2013. Deutsche Bank Securities and UBS Investment Bank are acting as the joint book-running managers of the offering. The Company intends to use the net proceeds of the offering to make investments relating to its business, to repurchase or pay its liabilities and for general corporate purposes.
How Should Investors Trade NRF After The Recent Movement? Find Out Here
Centrais Eletricas Brasileiras SA (ADR) (NYSE:EBR.B) shares jumped 5.84% and closed at $6.52. Eletropaulo Metropolitana Eletricidade de Sao Paulo SA (AES Eletropaulo), on Feb. 21, announced that, in context of a dispute over the loan contract signed on October 30, 1986, between the Company and CTEEP Companhia de Transmissao de Energia Eletrica Paulista, the Court of Justice of Rio de Janeiro has fully annulled a decision of the first instance. Thus, the process must be restarted in one instance to proceed with the analysis of the technical and legal issues, as well as to realize the accounting expertise. At the end of this procedure, there should be issued a new decision, which will indicate the responsible one and the amount due to Eletrobras - Centrais Eletricas Brasileiras SA.
Is EBR.B Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here
NxStage Medical, Inc. (NASDAQ:NXTM) shares gained 3.50% to $11.23 after the company yesterday reported record financial results for the three and twelve months ended December 31, 2012, that includes revenue above the top end of its guidance range. Revenue for the full-year 2012 increased 11 percent to $242.1 million, compared with revenue of $217.3 million for the full-year 2011. Revenue for the fourth quarter of 2012 increased 14 percent to a record $65.0 million compared with revenue of $57.0 million for the fourth quarter of 2011.
Is NXTM a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here
Zoetis Inc (NYSE:ZTS) shares climbed 3.50% and closed at $33.45. The company, on Feb. 6, announced the closing of its previously announced initial public offering. The offering of 99,015,000 shares of its Class A common stock included 12,915,000 shares of Class A common stock that were sold pursuant to the underwriters` option to purchase additional shares, which was exercised in full prior to the closing. Zoetis did not receive any of the proceeds of the offering. Following the completion of the initial public offering, Pfizer owns 100% of the outstanding Class B common stock of Zoetis and retains an approximately 80% ownership of Zoetis. J.P. Morgan, BofA Merrill Lynch and Morgan Stanley served as joint lead book-running managers for the offering.
How Should Investors Trade ZTS After The Latest Earnings Report? Find Out Here
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)